| Pharmaceutical Information |
| Drug Name |
Tramazoline |
| Drug ID |
BADD_D02256 |
| Description |
Tramazoline is under investigation in clinical trial NCT01601509 (Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and). |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
R01AA09 |
| DrugBank ID |
DB13064
|
| KEGG ID |
D08624
|
| MeSH ID |
C005370
|
| PubChem ID |
5524
|
| TTD Drug ID |
D0ZT8D
|
| NDC Product Code |
Not Available |
| Synonyms |
tramazoline | 2-(5,6,7,8-tetrahydro-1-naphthylamino)-2-imidazoline | tramazoline hydrochloride | tramazoline monohydrochloride | Rhinospray | Spray-Tish | Bisolnasal | Biciron | Ellatun | KB 227 |
|
| Chemical Information |
| Molecular Formula |
C13H17N3 |
| CAS Registry Number |
1082-57-1 |
| SMILES |
C1CCC2=C(C1)C=CC=C2NC3=NCCN3 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
